Knockout animals and natural mutations as experimental and diagnostic tool for studying tight junction functions in vivo  by Furuse, Mikio
Biochimica et Biophysica Acta 1788 (2009) 813–819
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamemReview
Knockout animals and natural mutations as experimental and diagnostic tool for
studying tight junction functions in vivo
Mikio Furuse ⁎
Division of Cell Biology, Department of Physiology and Cell Biology, Kobe University, Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan⁎ Tel.: +81 78 382 5805; fax: +81 75 382 5806.
E-mail address: furuse@med.kobe-u.ac.jp.
0005-2736/$ – see front matter © 2008 Elsevier B.V. A
doi:10.1016/j.bbamem.2008.07.017a b s t r a c ta r t i c l e i n f oArticle history: Two sides of functions of tig
Received 1 May 2008
Received in revised form 8 July 2008
Accepted 21 July 2008
Available online 28 July 2008
Keywords:
Tight junction
Claudin
Occludin
Tricellulin
ZO-1
ZO-2
Knockout mice
Hereditary diseaseht junctions; the barrier and the channel in the paracellular pathway are believed
to be essential for the development and physiological functions of organs. Recent identiﬁcation of molecular
components of tight junctions has enabled us to analyze their functions by generating knockout mice of the
corresponding genes. In addition, positional cloning has identiﬁed mutations in the genes of several
components of tight junctions in hereditary diseases. These studies have highlighted in vivo functions of tight
junctions.
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Tight junctions (TJs) contribute to epithelial and endothelial bar-
rier functions by restricting the diffusion of solutes through the para-
cellular pathway in vertebrate species [1]. This function of TJs enablesll rights reserved.isolation from the external environment and maintenance of distinct
ﬂuid compartments within the body, which are fundamental aspects
for the functions of most organ systems [1]. TJs are not complete
barriers, but rather contain pores through which ions and small
molecules pass passively with charge and size selectivities. Impor-
tantly, the barrier properties of TJs vary among different types of
epithelia depending on their physiological functions [2–6]. Transe-
pithelial electric resistance (TER), which is the easiest and most
Table 2
Tight junction-associated hereditary diseases
Gene Disease Ref.
Cldn-1 Neonatal ichthyosis and sclerosing cholangitis [24]
Cldn-14 Non-syndromic deafness (DFNB29) [8]
Cldn-16 Familial hypomagnesemia with hypercalciuria and
nephrocalcinosis (human)
[48]
Chronic interstitial nephritis and renal tubular dysplasia (bovine) [53,54]
Cldn-19 hypomagnesemia with hypercalciuria and nephrocalcinosis with
visual impairment
[59]
Tricellulin Non-syndromic deafness (DFNB49) [67]
ZO-2 Familial hypercholamenia [78]
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31, 000 Ω×cm2 [52]. The selectivities between cations and anions in
the paracellular pathway also vary among different types of epithelia
in vivo and in vitro [2–6]. Not only for leaky epithelia but also for
tight epithelia, TJs are important routes of epithelial transport, which
is the sum of transcellular and paracellular transport.
Although these functions of TJs are believed to be essential for the
development and physiological functions of organs, there have been
no experimental demonstrations of these aspects due to the lack of
appropriate methods for speciﬁcally modulating the functions of
TJs in vivo. However, the recent identiﬁcation of molecular compo-
nents of TJs has enabled us to analyze their functions by generating
knockout mice of the corresponding genes (Table 1). In addition,
positional cloning has identiﬁed mutations in the genes of several TJ
components in hereditary human and cattle diseases, further dem-
onstrating critical roles for TJs in various organs (Table 2). In this
review, the pathologies of knockout or knockdown mice and natural
mutations of the genes of TJ-associated structural proteins are sum-
marized, and the roles of TJs in vivo are discussed.
2. Knockouts and natural mutations of claudin family genes
Accumulating evidence has revealed that claudins are the major
barrier-forming proteins of TJs [2–6]. When claudins are over-
expressed in culturedﬁbroblasts, exogenous claudins are concentrated
from both sides of adjacent cells into cell–cell contact planes, where
well-developed TJ strands, the core structures of TJ barriers, are formed
de novo [7]. Claudins comprise a multigene family containing 24
members in the mouse and human genomes [3,4]. In most cell types,
multiple claudin types are coexpressed in individual cells and the
combinations and proportions of different claudins vary among cell
types [9]. This manner of claudin expression is thought to provide
functional diversity for the barrier properties of TJs, such as conduc-
tance and charge selectivity of ions, depending on the environment
of the extracellular domains of the claudins [10]. Indeed, a number
of studies have revealed that overexpression of a certain claudin in
cultured epithelial cells changes the barrier or channel properties of
TJs, as evaluated by measuring the TER and diffusion potential, which
indicate the charge selectivity of TJs [10–18]. The effects of over-
expression of each claudin depend not only on the type of claudin
overexpressed but also on the cell lines used, since each cell line has its
own barrier properties of TJs based on its unique background
expression pattern of claudins [19]. The aspects that can be measured
in such experiments are the barrier properties of TJs generated from
particular combinations of claudins, namely the endogenous claudins
and the overexpressed claudin. It is possible, however, that the effects
reﬂect the barrier-forming or channel-forming properties of the added
claudin types, with positive and negative charge selectivities. Thus, the
overall barrier properties of TJs in each epithelial type are determined
by the combination of claudin types expressed in each cell type.Table 1
Tight junction gene knockout (KO) and knockdown (KD) mice
Gene Phenotype Ref.
Cldn-1 KO Skin barrier defect to the water loss [23]
Cldn-5 KO Blood-brain barrier defect [30]
Cldn-11 KO CNS myelin defect, Blood-testis barrier defect [34]
Deafness [36,37]
Cldn-14 KO Phenocopy of human non-syndromic deafness [41]
Cldn-15 KO Megaintestine [44]
Cldn-16 KD Phenocopy of familial hypomagnesemia with
hypercalciuria and nephrocalcinosis
[49]
Cldn-19 KO Schwann cell barrier defect [57]
Occludin Viable with complex phenotype [63]
ZO-1 Embryonic lethal at E10.5 [77]
ZO-2 Embryonic lethal [85]
ZO-3 No phenotype [72,85]To date, many claudin gene knockout mice and mutations in
claudin genes related to hereditary human and cattle diseases have
been reported. Various pathologies have therefore come to be inter-
preted from the viewpoint of TJ barrier/channel deﬁcits. In addition,
mutation and morpholino suppressions of claudin genes in zebraﬁsh
have been reported.
2.1. Claudin-1-deﬁcient mice and claudin-1 gene mutations
The mammalian epidermis consists of a stratiﬁed epithelium with
four types of layers, namely the stratum basale, stratum spinosum,
stratum granulosum and stratum corneum. It is well known that
corniﬁed cell envelopes and the lipid lamella between them create a
strong barrier in the skin against physical stress, infection and water
dispersion [20]. On the other hand, the roles of TJs in the epidermis
have been ignored for a long time due to the difﬁculties associated
with identifying TJs in the skin by electron microscopy [21]. How-
ever, the recent identiﬁcation of TJ-associated proteins has enabled us
to re-examine the existence of TJs in the mammalian epidermis. Im-
munoﬂuorescence microscopy analyses have identiﬁed continuous
TJs surrounding keratinocytes in the stratum granulosum that in-
clude, at least, occludin, claudin-1 and claudin-4 [22,23].
Claudin-1-deﬁcient (Cldn1−/−) mice are born alive, but die within
1 day of birth due to excessive dehydration from the skin [23]. The skin
of Cldn1−/−mice looks macroscopically normal at birth, but gradually
begins to show a wrinkled appearance. The epidermis in Cldn1−/−
mice does not exhibit any overt abnormalities in the organization of
the keratinocyte layers, except that the stratum corneum appears to
be more compact than those of wild-type and heterozygous mice
under conventional ﬁxation/embedding conditions during sample
preparation for microscopy [23]. Morphological analyses by immuno-
ﬂuorescence and electron microscopy suggested the presence of
continuous TJs containing occludin and claudin-4 in the stratum
granulosum in Cldn1−/−mice [23]. However, these TJs are permeable
to awater-soluble tracer of ∼600 Da injected subcutaneously, whereas
this tracer cannot pass through TJs inwild-typemice. The lipid lamella
formed between corneocytes appears normal in Cldn1−/− mice [23].
Although claudin-1was demonstrated to be essential for the TJ barrier
in granular cells[23], the barrier function of the stratum corneum to
the water loss in these mice may also be affected, which should be
examined in the future study. The reason why claudin-1-deﬁcient
TJs, which still include at least claudin-4, become leaky is also an
open question.
Mutations in the claudin-1 gene have been identiﬁed in neonatal
ichthyosis and sclerosing cholangitis (NISCH) syndrome [24]. Origin-
ally, this syndrome was reported as autosomal recessive ichthyosis
with scalp hypotrichosis, scaling alopecia, sclerosing cholangitis,
oligodontia, enamel dysplasia and leukocyte vacuolization in four
patients in two inbred kindreds of Moroccan origin [25]. The disease
gene was mapped to chromosome 3q27–28, where a deletion of two
nucleotides led to a frameshift mutation that resulted in a premature
stop codon at amino acid 67 of claudin-1 [24]. Subsequently, a dif-
ferent frameshift mutation leading to a premature stop codon at
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family [26]. In the liver of these patients, no claudin-1 protein was
detected by immunoblotting analyses using anti-claudin-1 antibodies
generated against the C-terminal cytoplasmic domain of claudin-1
[24]. Although the detailed mechanism of this syndrome is not yet
understood, the major symptoms of the syndrome, namely sclerosing
cholangitis and ichthyosis, appear to be related to the lack of ex-
pression of claudin-1 in the liver and skin [23,27]. In the liver, claudin-
1 is a component of TJs in the bile canaliculi, through which the bile
acid generated in hepatocytes ﬂows into the bile duct [27]. In the
skin, claudin-1 is a component of TJs in the stratum granulosum in
the epidermis [22,23]. The mechanism behind the skin defects in
NISCH syndrome may be further clariﬁed by analyzing the pheno-
types of claudin-1-deﬁcient mice, especially those of skin grafts to
nude mice.
2.2. Claudin-5-deﬁcient mice
The TJs in brain endothelial cells are well-developed compared
with those in endothelial cells in other organs and establish the blood-
brain barrier (BBB) [28,29]. The BBB is thought to protect the brain
against harmful materials circulating in the blood and maintain a
stable solute environment in the cerebrospinal ﬂuid. Claudin-5 is the
major known component of TJs in brain endothelial cells [30].
Cldn-5−/−mice are born alive in the expectedMendelian ratio, but
die within 1 day of birth [60]. The development of blood vessels in
Cldn-5−/− mice appears normal and no bleeding or edema is
observed. In ultrathin section electron microscopy, the brain endothe-
lial cells of newborn Cldn-5−/− mice have TJs with normal
appearances at cell–cell contact sites [60]. However, tracer experi-
ments revealed that the BBB against small water-soluble molecules,
but not larger molecules, is selectively affected in these mice. When a
tracer of 443 Da (a primary amine-reactive biotinylation reagent) was
perfused via the heart of wild-type 18.5-d embryos for 5 minutes, the
tracer was retained in the blood vessels in the brain and excluded from
the central nervous system (CNS). In contrast, the tracer was
distributed throughout the brain parenchyma in Cldn-5−/− mice,
indicating that the BBB is severely affected in these mice [60]. When
microperoxidase (1.9 kDa) was used as a tracer, however, its leakage
from blood vessels was not observed [60]. The mechanism behind this
size discrimination remains elusive. The reason why Cldn-5−/− mice
die just after birth is also unclear.
2.3. Claudin-11-deﬁcient mice
Claudin-11 was originally identiﬁed as oligodendrocyte-speciﬁc
protein since it represents one of the major components of oligo-
dendrocytes [31]. Claudin-11 is expressed in speciﬁc organs, including
oligodendrocytes, in the brain [31,32,34], Sertoli cells in the testis
[32,34] and the basal cell layer of the stria vascularis (SV) in the
cochlea [33,34,36]. Since claudin-11 seems to be the sole claudin in
these cell types, claudin-11-deﬁcient mice exhibit various pathologi-
cal conditions without compensation by other claudin types.
CNS myelin, which is generated by oligodendrocytes, is not an
epithelium, but contains TJs formed from claudin-11 [32,34]. These TJs
run parallel to the axon axis and radially through the myelin sheath,
comprising the so-called radial component. Cldn-11−/− mice do
not exhibit demyelination, but lack TJ strands in the CNS myelin,
as observed by freeze-fracture replica electron microscopy [34].
Cldn-11−/− mice show hind limb weakness and slowed conduction
velocities in the CNS, suggesting that TJs in oligodendrocytes are
involved in the tight electric sealing of myelin in the CNS [34].
The blood-testis barrier (BTB) separates the environment of the
testis, where sperm is generated, from the blood. The proposed func-
tion of the BTB is to provide a specialized compartment to facilitate
the development of spermatozoa [79,80]. Furthermore, BTB is thoughtto protect developing spermatozoa, which mature after immunotol-
erance is established, against autoimmune responses [35]. In Sertoli
cells, which are specialized epithelial cells for generating seminiferous
tubules, TJs are the major component of the BTB [35]. Cldn-11−/−
male mice lack TJ strands in their Sertoli cells and show male sterility
accompanied by small seminiferous tubules without spermatozoa,
but not autoimmune responses [34]. These observations suggest that
TJs in the BTB function in the generation of the solute environment
critical for spermatogenesis rather than in the avoidance of auto-
immune responses.
Cldn-11−/− mice also suffer from deafness [36,37]. The cochlea
includes a peculiar compartment ﬁlled with endolymph [38]. This
compartment is characterized by a very high K+ concentration
(∼150 mM) and a positive endocochlear potential (EP; ∼90 mV),
which are both indispensable for cochlear hair cells to transduce
acoustic stimuli into electrical signals [39,40]. These conditions are
thought to be generated by the SV, which faces toward the endolymph
[39,40]. The SV has two epithelial barriers, termed the marginal and
basal cell layers. The TJs of the basal cell layer are primarily composed
of claudin-11 [33,34]. In Cldn-11−/− mice, the basal cells lack TJs and
the hearing ability is markedly reduced [36,37]. In thesemice, the EP is
suppressed to ∼30 mV, although the K+ concentration of the endo-
lymph is maintained around the normal level, indicating that the TJs
in the basal cells play a role in establishing the EP [36,37].
Due to the peculiar tissue expression pattern of claudin-11,
Cldn-11−/−mice exhibit rather diverse symptoms. To date, no human
hereditary syndromes with a combination of slowed conduction
velocities in the CNS, male sterility and deafness have been reported.
2.4. Claudin-14 gene mutations and claudin-14-deﬁcient mice
Mutations in the claudin-14 gene were identiﬁed as the cause of
non-syndromic recessive deafness DFNB29, which was mapped on
chromosome 21q22.1, in two Pakistani families [8]. In the affected
individuals in one family, a homozygous single nucleotide deletion
was found within the codon for Met133, which is located in the third
transmembrane domain. The resulting frameshift mutation causes
23 incorrect amino acids and premature termination, with the loss
of the C-terminal half of the full-length protein. Another mutation
identiﬁed in the affected individuals is a homozygous missense
mutation that substitutes aspartic acid for valine 85 in the second
transmembrane domain. In situ hybridization and immunoﬂuores-
cence staining revealed claudin-14 expression in the hair cells of the
organ of Corti in the mouse cochlea [8], which includes a peculiar
compartment ﬁlled with endolymph that is characterized by a very
high K+ concentration and a positive EP [38–40].
As a mouse model for DFNB29, claudin-14-deﬁcient mice were
generated. Cldn-14−/− mice exhibit profound hearing loss with a
normal EP [41]. In Cldn-14−/− mice, inner hair cells and outer hair
cells (OHCs) develop normally by P7, but the OHCs subsequently
disappear or become disorganized. By P18, most of the OHCs are lost
[41]. Since the OHC degeneration coincides with elevation of K+ in the
endolymph during development, it has been proposed that leakage
of the high K+ concentration to the basolateral domain of OHCs due
to the reduced TJ barrier under the loss of claudin-14 may cause
prolonged OHC depolarization, thereby leading to death of the OHCs
[41]. Claudin-14 is expressed in the liver and kidney, but abnormal-
ities in these organs have not been observed.
2.5. Claudin-15-deﬁcient mice
Intestinal epithelial cells express various claudin types, including
at least claudin-2, -3, -4, -7, -12 and -15, as evaluated by immuno-
ﬂuorescence staining [42,43]. Among these, claudin-15 is concen-
trated in the TJs of all intestinal epithelial cells throughout the mouse
intestinal tube [43]. Claudin-15-deﬁcient mice are born alive and grow
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able differences in the overall morphologies of the small intestine
betweenwild-type and Cldn-15−/−mice. However, adult Cldn-15−/−
mice show an abnormally expanded intestine, referred to as a mega-
intestine phenotype [44]. The upper small intestine, duodenum and
jejunum in Cldn-15−/− mice are increased by approximately 2-fold
compared to those inwild-typemice. Histologic examination revealed
that the sizes of the intestinal villi are signiﬁcantly increased in the
upper intestine without a pathological state [44]. A BrdU incorpora-
tion study revealed that the proliferation zone of the small intestine
is expanded by approximately 2-fold in length along the crypt in
Cldn-15−/− mice, while apoptosis is unaffected, indicating that cell
proliferation is enhanced in Cldn-15−/− mice [44]. Polyp/cancer for-
mationwas not observed in 2-year-old Cldn-15−/−mice [44]. Electro-
physiological analyses demonstrated that the ion conductance in the
distal portion of the jejunum in Cldn-15−/− mice is decreased,
although neither wild-type nor Cldn-15−/− mice show remarkable
permeability to water-soluble tracers of more than ∼400 Da [44]. The
molecular mechanisms for how claudin-15-deﬁciency induces these
interesting phenotypes remain unclear.
2.6. Claudin-16 mutations and claudin-16-deﬁcient mice
In the kidney, nutrients and electrolytes are reabsorbed while
primary urine ﬂows in nephron segments, characterizing the intense
epithelial transport in this organ. The epithelial cells in each nephron
segment express speciﬁc sets of membrane transporters and claudin
types to achieve their unique properties of epithelial transport, which
is composed of transcellular and paracellular pathways [45]. In the
kidney, Mg2+ is predominantly reabsorbed in the thick ascending
limb (TAL) of Henle via a paracellular pathway [46]. A luminal positive
transepithelial potential is established in the TAL, and this potential
and the chemical gradient are thought to provide the driving force for
Mg2+ reabsorption [47].
Claudin-16 was initially reported as paracellin-1, which is the cau-
sative gene for a rare human autosomal recessive hereditary disease
termed familial hypomagnesemia with hypercalciuria and neph-
rocalcinosis (FHHNC)with severe renalMg2+wasting [48]. Expression
of claudin-16 is restricted to the TAL, whereMg2+ ions are reabsorbed.
The claudin-16 gene was mapped on chromosome 3q27 [49], and
several nonsense mutations and many point mutations in the ex-
tracellular, transmembrane and cytoplasmic domains have been
identiﬁed in FHHNC [48–50,81,82]. Since the symptoms of FHHNC
are excessive urinary excretions of Mg2+ and Ca2+ ions, it was once
hypothesized that claudin-16 forms a selective channel for divalent
cations, including Mg2+ and Ca2+, for their reabsorption [48].
However, recent intensive studies of claudin-16-deﬁcient (knock-
down) mice as well as claudin-16-overexpressing epithelial cells
support the idea that claudin-16 creates a non-selective cation channel.
Claudin-16-deﬁcient mice were recently generated using RNA in-
terference (RNAi) technology [51]. These claudin-16 knockdown
(Cldn-16 KD) mice show signiﬁcantly reduced plasma Mg2+ levels
and excessive urinary excretions of Mg2+ and Ca2+. Furthermore,
calcium deposits are observed in the basement membranes of the
medullary tubules and the interstitium in the kidney of adult Cldn-16
KD mice. These phenotypes of Cldn-16 KD mice are very similar to
the symptoms in human FHHNC patients.
Electrophysiological analyses of isolated TALs revealed that the
paracellular pathway of the TAL is cation-selective without discrimi-
nation among monovalent (Na+) and divalent (Mg2+/Ca2+) cations
in wild-type mice and that this cation selectivity is signiﬁcantly
reduced in Cldn-16 KD mice, suggesting that claudin-16 works as a
non-selective cation channel in the TAL [51]. These conclusions for the
TAL are consistent with those obtained from in vitro analyses of
claudin-16-overexpressing LLC-PK1 epithelial cells by the same
research group [15]. Based on these studies, a model explainingclaudin-16-deﬁciency has been proposed [51]. According to this
model, the luminal positive transepithelial potential in the TAL,
which is the driving force for Mg2+ reabsorption, is primarily
generated by the diffusion potential. In the TAL, NaCl is electro-
genically absorbed, resulting in NaCl concentration in the basolateral
extracellular space and a diluted ﬂuid in the lumen. A diffusion
potential occurs between these spaces since the TJs formed by claudin-
16 in the TAL are cation-selective, thereby generating the luminal
positive potential of the TAL. Claudin-16-deﬁciency results in the loss
of cation selectivity of TJs in the TAL, ﬁnally leading to dissipation of
the luminal positive potential and loss of Mg2+ reabsorption.
In addition to the hereditary human disease FHHNC, a null muta-
tion of claudin-16 has been reported in cattle, which results in chronic
interstitial nephritis and renal tubular dysplasia [53,54]. The clinical
features of the bovine disease differ from those of the human disease,
but the mechanisms behind these differences are not yet understood.
2.7. Claudin-19-deﬁcient mice and claudin-19 gene mutations
In the myelinated axons of the peripheral nervous system (PNS),
the existence of TJ strand-like structures has been reported within
Schwann cells [55,56]. These structures are densely and spirally
concentrated at the Schmidt–Lanterman incisures and paranodes, and
occur as two parallel lines along the outer and inner mesaxons.
Claudin-19 is expressed in large amounts in the PNS, but not the CNS,
and constitutes these TJ-like structures in Schwann cells [57]. Claudin-
19-deﬁcient mice are born alive and grow normally, but show be-
havioral abnormalities that can be attributed to PNS deﬁcits [57].
Consistently, ultrathin election electron microscopy has revealed
that membrane contacts of the TJ-like structures in the outer and
inner mesaxons observed in wild-type mice are never observed in
Cldn-19−/−mice [57]. The overall organization of the myelin remains
unchanged in Cldn-19−/− mice. One possibility is that claudin-19-
based TJs in Schwann cells function for electric sealing in myelin,
although this has not yet been demonstrated.
Claudin-19 is also expressed in the TAL, the major site of para-
cellular Mg2+ reabsorption in the kidney [58]. Mutations in the
claudin-19 gene are associated with recessive magnesium wasting,
whose locus was mapped on chromosome 1p34.2 [59]. The renal
phenotype in these patients is very similar to that of FHHNC patients
with claudin-16 mutations, although the patients also have visual
impairment. Consistent with the latter phenotype, claudin-19 is ex-
pressed in retinal pigmental epithelial cells, at least in zebraﬁsh [59].
In vitro analyses demonstrated that claudin-19 functions as a Cl−
blocker at TJs in LLC-PK1 epithelial cells, while claudin-16 functions
as a Na+ channel [17]. Very recently, it has been shown that claudin-16
and claudin-19 form a physical complex within cells and generate
cation selectivity of TJs in a synergistic manner [17].
2.8. Claudin-deﬁcient zebraﬁsh
Zebraﬁsh Danio relio is another useful vertebrate model for gen-
etic analyses of gene function in vivo. An insertional mutation in the
claudinj gene at the 3′ untranslated region results not only in smaller
otoliths in the ear but also in hearing and vestibular dysfunction [83].
In situ hybridization revealed that claudinj is expressed in ear and
brain. Morpholino inhibition of cldnj expression showed similar
defects in otoliths formation [83]. Although the mechanism how oto-
liths formation is affected remains unclear, one possibility is that the
assembly of otolith material is inhibited due to altered ionic envi-
ronment in the ear caused by claudinj mutation [83].
Zebraﬁsh claudin-15 is expressed in the gut under the control of
Tcf2 transcription factor [84]. Morpholino suppression of claudin-15
results in the multi-lumen formation in the gut [84]. The expression
of claudin-15 creates cation pores and promotes single lumen for-
mation in 3D-cultured MDCK cells [84]. Therefore, claudin-15 seems
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ﬂuid accumulation, which is controlled by the paracellular transport
of ions through claudin-15-containing TJs [84].
3. Occludin-deﬁcient mice
Occludin was identiﬁed as the ﬁrst transmembrane component
of TJs [61]. Occludin has a molecular mass of ∼65 kDa and is com-
posed of four transmembrane domains, two extracellular loops, a long
C-terminal cytoplasmic domain, an N-terminal cytoplasmic domain
and one intracellular turn. The TJs in most epithelial cells contain
occludin, which is thought to be incorporated into claudin-based TJ
strands [62]. However, its physiological function is not yet understood.
Occludin-deﬁcient (OCLN−/−) mice possess morphologically normal
TJs [63]. Intensive electrophysiological analyses in Ussing chambers
have revealed no obvious differences in the epithelial transport and
barrier functions between normal and OCLN−/− mice [63,64]. How-
ever, OCLN−/− mice exhibit various complex phenotypes, including
chronic inﬂammation and hyperplasia of the gastric epithelium,
calciﬁcation in thebrain, testicular atrophy, loss of cytoplasmic granules
in striated duct cells of the salivary gland and thinning of the compact
bone [63]. These phenotypes cannot be simply explained in terms of
barrier dysfunction of TJs. The gastric phenotype of OCLN−/− mice
indicates that occludin may be involved in epithelial differentiation.
4. Tricellulin mutations
TJs circumscribe cells and function as barriers/channels in the
paracellular pathway. To bemore exact, TJs should be divided into two
types, namely bicellular TJs (bTJs), which are formed by claudins
between two adjacent cells, and tricellular TJs (tTJs), which occur at
regions where three cells come into contact [65]. Since claudins act to
form TJs between two cells, tTJs cannot simply be sealed by claudin-
based TJ strands like bTJs. Freeze-fracture electron microscopy
analyses have revealed that the TJ strands of bTJs approach from
both sides to the very limit of the edge of the tricellular contact region,
and then extend basolaterally [65]. As a result, a very narrow tube is
formed at the extracellular region of a tricellular contact in the api-
cobasal direction. Although tTJs have been ignored for a long time, it
is obvious that bTJs and tTJs should be considered separately in the
context of the barrier functions of TJs.
Tricellulin is a recently discovered membrane protein that is con-
centrated in tTJs in various epithelial cells [66]. Tricellulin has four
transmembrane domains and exhibits sequence similarity to occludin.
In particular, its C-terminal cytoplasmic domain shows high se-
quence similarity to the same region of occludin, to which ZO-1 binds
[66]. In vitro analyses revealed that this domain of tricellulin also
binds to ZO-1 [67]. When the expression of tricellulin was suppressed
by RNAi in mouse cultured epithelial cells, the barrier function of the
epithelial cellular sheet became compromised and not only tTJs but
also bTJs were disorganized, indicating crucial roles for tricellulin in
the formation tTJs as well as bTJs [66].
Recessive mutations of the tricellulin gene cause human non-
syndromic deafness DFNB49 [67,68]. In mouse inner ears, tricellulin is
found at tricellular contacts in most epithelial cells of the cochlea. In
particular, the sensory epithelium of the organ of Corti shows re-
markable localization of tricellulin along the entire depth of the
tricellular region of the lateral membrane, reﬂecting well-developed
tTJs between the OHCs and supporting cells [67]. All four mutations
reported to date result in the loss of all or most of the conserved region
in the C-terminal cytoplasmic domain, namely the occludin-ELL
domain, which is required for ZO-1 binding [67]. These ﬁndings
suggest that tricellulin mutants lacking the C-terminal cytoplasmic
domain are sufﬁcient for epithelial barrier functions in many tissues,
but cannot maintain a very strong barrier in the inner ear due to its
unusually steep concentration gradient of electrolytes.5. Knockout mice and mutations of ZO-1, ZO-2 and ZO-3 genes
Many peripheral membrane proteins underlying the cytoplasmic
surface of TJs have been identiﬁed. Among them, three closely related
proteins, ZO-1, -2 and -3, are thought to be directly involved in TJ
formation [69]. These proteins belong to the membrane-associated
guanylate kinase (MAGUK) family, containing three PDZ domains
(PDZ1, -2 and -3), one src homology 3 (SH3) domain and one gua-
nylate kinase-like (GUK) domain from their N-termini. The PDZ1
domains of all these proteins bind to the cytoplasmic tails of claudins
in vitro and normal claudins overexpressed in mouse L ﬁbroblasts
recruit these MAGUKs to reconstituted TJ strands, whereas C-
terminal-deleted claudins do not [70]. The establishment of mouse
epithelial cells lacking expression of ZO-1, -2 and -3 has revealed that
ZO-1 or ZO-2 is required for TJ formation by claudin polymerization
in epithelial cells, suggesting redundant functions of ZO-1 and ZO-2,
at least for TJ formation [71]. In contrast, ZO-3 is dispensable for TJ
formation in these cells, although it is speciﬁcally expressed in
epithelial cells [72]. Overexpression of various ZO-1-deleted con-
structs in mouse epithelial cells lacking expression of ZO-1, -2 and -3
suggested that dimerization of ZO-1 beneath the plasma mem-
brane triggers TJ formation by claudins [71]. Interestingly, in addition
to the role of ZO-1 in TJ formation, detailed analyses of these cells
further showed that ZO-1 is involved in adherens junction (AJ)
formation through activation of Rac [73]. This observation seems to be
consistent with the previously reported relationship between ZO-1
and AJs. ZO-1 is initially recruited to cadherin-based AJs during cell
contact formation and then becomes distributed to TJs according to
cell polarity formation [74]. In addition, ZO-1 and ZO-2 are com-
ponents of AJs in, for example, cardiac muscle cells, which do not
have TJs [75,76].
ZO-1-deﬁcient mice have been reported very recently [77]. ZO-1−/
−mice die at embryonic stage E10.5. Tjp1−/− embryos appear normal
up to E8.5, but exhibit severe growth defects at E9.5, a signiﬁcant
reduction in size and the absence of turning with apoptosis in the
notochord, neural tube area and allantois [77]. In the yolk sack, Tjp1−/
− mice show defects in vascular development with abnormal
angiogenesis, possibly due to defects in cell–cell adhesion-related
tissue remodeling [77]. These phenotypes indicate critical roles for
ZO-1 in development, and should be further analyzed from the
viewpoint of AJ formation as well as TJ formation.
A nucleotide substitution in the ZO-2 gene was identiﬁed in
familial hypercholanemia (FHC), which was mapped to chromosome
9q12–q13 [78]. The affected patients have a point mutation (135C),
which is predicted to cause a valine-to-alanine substitution (V48A) in
the ZO-2 protein [78]. Themutated valine lies within the PDZ1 domain
of ZO-2 and is highly conserved in many PDZ domains as a branched
hydrophobic residue. In vitro analyses demonstrated that the V48A
mutation affects binding to the C-terminal region of claudins. This
mutation is not the sole cause of this type of FHC, which is very
rare, since the frequency of this mutation is high (7%), indicating
oligogenic inheritance [78]. Although the V48A substitution has
been proposed to cause increased paracellular permeability to bile
acids from the bile to the plasma, its detailed mechanism remains
totally unknown.
ZO-2-deﬁcient mice have been reported very recently [85]. ZO-2−/
− embryos die shortly after implantation. Egg cylinders of ZO-2−/−
embryos do not show mesoderm development with reduced cell
proliferation followed by apoptosis [85]. Ectoderm of E6.5 and E7.5
embryos show reduced electron dense plaque of the cytoplasmic
region of TJs and barrier defect to lanthanum tracer although their
epithelial polarity appears normal [85]. Although ZO-2−/− embryoid
bodies do not show obvious abnormality in the structure and barrier
function of TJs probably due to redundant function of ZO-1 [85], subtle
change in TJ function by ZO-2-deﬁcinecy may be enough to affect
the development of mouse embryo.
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speciﬁc expression of ZO-3 [72,85]. On the other hand, morpholino
inhibition of ZO-3 in zebraﬁsh embryogenesis results in various
abnormalities such as edema, loss of blood circulation, and tail ﬁn
malformations [86]. These phenotypes accompany with partial
disruption of TJ structure and permeability barrier [86], suggesting
the difference in the contribution of ZO-1, ZO-2, and ZO-3 to TJs
among species.
6. Conclusions
Many pathologies of knockout mice and mutations of the claudin
and tricellulin genes in hereditary human diseases have been in-
terpreted as defects in TJ functions. As observed for claudin-16 muta-
tions, however, the pathologies are also caused by the impaired
channel properties of TJs for selective paracellular transport, i.e. ab-
normal strengthening of the TJ barrier function. We should note that
these two sides of TJ-associated diseases are brought about by varia-
tions in the types of claudins, which display unique barrier or channel
properties. Due to the complex expression patterns of claudins, the
pathologies of the mice and natural disorders vary. As seen in NISCH
syndrome with a claudin-1 mutation and Cldn-11−/− mice, syndro-
mic symptoms appear to be derived from the peculiar tissue
expression patterns of these claudins.
Furthermore, it is of interest that mutations in tricellulin, which
is expressed in most epithelial cells and seems to be involved in the
barrier functions of TJs in general, were identiﬁed in one of the fam-
ilial non-syndromic deafness (DFNB) diseases. Since the inner ear
has to be equipped with very strong TJ barriers to maintain its un-
usually steep concentration gradient of electrolytes for hearing, it is a
very sensitive system for detecting defects in TJ barrier functions
from the pathology of deafness. Further positional cloning of causa-
tive genes for DFNB diseases may lead to the identiﬁcation of novel
molecular components required for the barrier functions of TJs.
On the other hand, knockout mice for several claudins and oc-
cludin exhibit their phenotypes through cell death or cell growth, and
these effects still cannot be directly interpreted as defects in the
barrier functions of TJs. Indeed, the signaling function of TJs has
been so far proposed [87,88]. Further analyses of these phenotypes
will be useful toward clarifying the complex roles of TJs in vivo.Acknowledgements
M.F. is supported by a Grant-in-Aid for Cancer Research from
the Ministry of Education, Culture, Sports, Science, and Technology
of Japan.References
[1] J.M. Anderson, M. Cereijido, Introduction: evolution of ideas on the tight junction,
in: M. Cereijido, J.M. Anderson (Eds.), Tight Junctions, CRC Press, Boca Raton, 2001,
pp. 1–18.
[2] D.W. Powell, Barrier function of epithelia, Am. J. Physiol. 241 (1981) G275–G288.
[3] C.M. Van Itallie, J.M. Anderson, The molecular physiology of tight junction pores,
Physiology 19 (2004) 331–338.
[4] M. Furuse, S. Tsukita, Claudins in occluding junctions of humans and ﬂies, Trend
Cell Biol. 16 (2006) 181–188.
[5] C.M. Van Itallie, J.M. Anderson, Claudins and epithelial paracellular transport,
Annu. Rev. Physiol. 68 (2006) 403–429.
[6] S. Angelow, A.S. Yu, Claudins and paracellular transport: an update, Curr. Opin.
Nephrol. Hypertens. 16 (2007) 459–464.
[7] M. Furuse, K. Fujita, T. Hiiragi, K. Fujimoto, S. Tsukita, A single gene product,
claudin-1 or claudin-2, reconstitutes tight junction strands and recruits occludin
in ﬁbroblasts, J. Cell Biol. 143 (1998) 1539–1550.
[8] E.R. Wilcox, Q.L. Burton, S. Naz, S. Riazuddin, T.N. Smith, B. Ploplis, I. Belyantseva, T.
Ben-Yosef, N.A. Liburd, R.J. Morell, B. Kachar, D.K.Wu, A.J. Grifﬁth, S. Riazuddin, T.B.
Friedman, Mutations in the gene encoding tight junction claudin-14 cause auto-
somal recessive deafness DFNB29, Cell 12 (2001) 165–172.
[9] S. Tsukita, M. Furuse, Pores in the wall: claudins constitute tight junction strands
containing aqueous pores, J. Cell Biol. 149 (2008) 13–16.[10] O.R. Colegio, C.M. Van Itallie, H.J. McCrea, C. Rahner, J.M. Anderson, Claudins create
charge-selective channels in the paracellular pathway between epithelial cells,
Am. J. Physiol. Cell Physiol. 283 (2002) C142–C147.
[11] C. Van Itallie, C. Rahner, J.M. Anderson, Regulated expression of claudin-4
decreases paracellular conductance through a selective decrease in sodium
permeability, J. Clin. Invest. 107 (2001) 1319–1327.
[12] M. Furuse, K. Furuse, H. Sasaki, S. Tsukita, Conversion of Zonulae occludentes from
tight to leaky strand type by introducing claudin-2 into Madin–Darby canine
kidney I cells, J. Cell Biol. 153 (2001) 263–272.
[13] S. Amasheh, N. Meiri, A.H. Gitter, T. Schöneberg, J. Mankertz, J.D. Schulzke, M.
Fromm, claudin-2 expression induces cation-selective channels in tight junctions
of epithelial cells, J. Cell Sci. 115 (2002) 4946–4976.
[14] A.S. Yu, A.H. Enck, W.I. Lencer, E.E. Schneeberger, Claudin-8 expression in Madin–
Darby canine kidney cells augments the paracellular barrier to cation permeation,
J. Biol. Chem. 278 (2003) 17350–17359.
[15] J. Hou, D.L. Paul, D.A. Goodenough, Paracellin-1 and the modulation of ion
selectivity of tight junctions, J. Cell Sci. 118 (2005) 5109–5118.
[16] C.M. Van Itallie, S. Rogan, A. Yu, L.S. Vidal, J. Holmes, J.M. Anderson, Two splice
variants of claudin-10 in the kidney create paracellular pores with different ion
selectivities, Am. J. Physiol. Renal Physiol. 291 (2006) F1288–F1299.
[17] J. Hou, A. Renigunta, M. Konrad, A.S. Gomes, E.E. Schneeberger, D.L. Paul, S.
Waldegger, D.A. Goodenough, Claudin-16 and claudin-19 interact and form a
cation-selective tight junction complex, J. Clin. Invest. 118 (2008) 619–628.
[18] B. Jovov, C.M. Van Itallie, N.J. Shaheen, J.L. Carson, T.M. Gambling, J.M. Anderson,
R.C. Orlando, Claudin-18: a dominant tight junction protein in Barrett's esophagus
and likely contributor to its acid resistance, Am. J. Physiol. Gastrointest. Liver
Physiol. 293 (2007) G1106–G1113.
[19] C.M. Van Itallie, A.S. Fanning, J.M. Anderson, Reversal of charge selectivity in
cation or anion-selective epithelial lines by expression of different claudins, Am.
J. Physiol. Renal Physiol. 285 (2003) F1078–F1084.
[20] J. Segre, Complex redundancy to build a simple epidermal permeability barrier,
Curr. Opin. Cell Biol. 15 (2003) 778–784.
[21] P.M. Elias, D.S. Friend, The permeability barrier in mammalian epidermis, J. Cell
Biol. 65 (1975) 180–191.
[22] J.M. Brandner, S. Kief, C. Grund, M. Rendl, P. Houdek, C. Kuhn, E. Tschachler, W.W.
Franke, I. Moll, Organization and formation of the tight junction system in human
epidermis and cultured keratinocytes, Eur. J. Cell Biol. 81 (2002) 253–263.
[23] M. Furuse, M. Hata, K. Furuse, Y. Yoshida, A. Haratake, Y. Sugitani, T. Noda, A. Kubo,
S. Tsukita, Claudin-based tight junctions are crucial for the mammalian epi-
dermal barrier: a lesson from claudin-1-deﬁcient mice, J. Cell Biol. 156 (2002)
1099–1111.
[24] S. Hadj-Rabia, L. Baala, P. Vabres, D. Hamel-Teillac, E. Jacquemin, M. Fabre, S.
Lyonnet, Y. De Prost, A. Munnich, M. Hadchouel, A. Smahi, Claudin-1 gene muta-
tions in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction
disease, Gastroenterology, 127 (2004) 1386–1390.
[25] L. Baala, S. Hadj-Rabia, D. Hamel-Teillac, M. Hadchouel, C. Prost, S.M. Leal, E.
Jacquemin, A. Seﬁani, Y. De Prost, G. Courtois, A. Munnich, S. Lyonnet, P. Vabres,
Homozygosity mapping of a locus for a novel syndromic ichthyosis to
chromosome 3q27–q28, J. Invest. Dermatol. 119 (2002) 70–76.
[26] L. Feldmeyer, M. Huber, F. Fellmann, J.S. Beckmann, E. Frenk, D. Hohl, Conﬁrmation
of the origin of NISCH syndrome, Hum. Mutat. 27 (2006) 408–410.
[27] M. Furuse, K. Fujita, T. Hiiragi, K. Fujimoto, S. Tsukita, Claudin-1 and -2: novel
integral membrane proteins localizing at tight junctions with no sequence
similarity to occludin, J. Cell Biol. 141 (1998) 1539–1550.
[28] W.M. Pardridge, Introduction to the Blood-brain Barrier, Cambridge University
Press, Cambridge 486 pp.
[29] T.S. Reese, M.J. Karnovsky, Fine structural localization of a blood-brain barrier to
exogenous peroxidase, J. Cell Biol. 34 (1967) 207–217.
[30] K. Morita, H. Sasaki, M. Furuse, S. Tsukita, Endothelial claudin: claudin-5/TMVCF
constitutes tight junction strands in endothelial cells, J. Cell Biol. 147 (1999)
185–194.
[31] J.M. Bronstein, P.E. Micevych, K. Chen, Oligodendrocyte-speciﬁc protein (OSP) is a
major component of CNS myelin, J. Neurosci. Res. 50 (1997) 713–720.
[32] K. Morita, H. Sasaki, K. Fujimoto, M. Furuse, S. Tsukita, Claudin-11/OSP-based tight
junctions of myelin sheaths in brain and Sertoli cells in testis, J. Cell Biol. 145
(1999) 579–588.
[33] S.I. Kitajiri, M. Furuse, K. Morita, Y. Saishin-Kiuchi, H. Kido, J. Ito, S. Tsukita,
Expression patterns of claudins, tight junction adhesion molecules, in the inner
ear, Hear Res. 187 (2004) 25–34.
[34] A. Gow, C.M. Southwood, J.S. Li, M. Pariali, G.P. Riordan, S.E. Brodie, J. Danias, J.M.
Bronstein, B. Kachar, R.A. Lazzarini, CNS myelin and Sertoli cell tight junction
strands are absent in Osp/claudin-11 null mice, Cell 99 (1999) 649–659.
[35] M.D. Griswold, Interactions between germ cells and Sertoli cells in the testis, Biol.
Reprod. 52 (1995) 211–216.
[36] A. Gow, C. Davies, C.M. Southwood, G. Frolenkov, M. Chrustowski, L. Ng, D.
Yamauchi, D.C. Marcus, B. Kachar, Deafness in Claudin 11-null mice reveals the
critical contribution of basal cell tight junctions to stria vascularis function, J.
Neurosci. 24 (2004) 7051–7062.
[37] S. Kitajiri, T. Miyamoto, A. Mineharu, N. Sonoda, K. Furuse, M. Hata, H. Sasaki, Y.
Mori, T. Kubota, J. Ito, M. Furuse, S. Tsukita, Compartmentalization established by
claudin-11-based tight junctions in stria vascularis is required for hearing through
generation of endocochlear potential, J. Cell Sci. 117 (2004) 5087–5096.
[38] E. Fervary, O. Sterkers, Mechanism of endolymph secretion, Kidney Int. 65 (1998)
S98–S103.
[39] P. Wangemann, K+ cycling and the endocochlear potential, Hear Res. 165 (2002)
1–9.
819M. Furuse / Biochimica et Biophysica Acta 1788 (2009) 813–819[40] P. Wangemann, J. Liu, D.C. Marcus, Ion transport mechanisms responsible for
K+ secretion and the transepithelial voltage across marginal cells of stria
vascularis in vitro, Hear Res. (1995) 19–29.
[41] T. Ben-Yosef, I.A. Belyantseva, T.L. Saunders, E.D. Hughes, K. Kawamoto, C.M. Van
Itallie, L.A. Beyer, K. Halsey, D.J. Gardner, E.R. Wilcox, J. Rasmussen, J.M. Anderson,
D.F. Dolan, A. Forge, Y. Raphael, S.A. Camper, T.B. Friedman, Claudin 14 knockout
mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear
hair cell degeneration, Hum. Mol. Genet. 12 (2003) 2049–2061.
[42] C. Rahner, L.L. Mitic, J.M. Anderson, Heterogeneity in expression and subcellular
localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut,
Gastroenterology 120 (2001) 411–422.
[43] H. Fujita, H. Chiba, H. Yokozaki, N. Sakai, K. Sugimoto, T. Wada, T. Kojima, T.
Yamashita, N. Sawada, Differential expression and subcellular localization of
claudin-7, -8, -12, -13, and -15 along the mouse intestine, J. Histochem. Cytochem.
54 (2006) 933–944.
[44] A. Tamura, Y. Kitano, M. Hata, T. Katsuno, K. Moriwaki, H. Sasaki, H. Hayashi, Y.
Suzuki, T. Noda, M. Furuse, S. Tsukita, S. Tsukita, Megaintestine in claudin-15-
deﬁcient mice, Gastroenterology 134 (2008) 523–534.
[45] Y. Kiuchi-Saishin, S. Gotoh, M. Furuse, A. Takasuga, Y. Tano, S. Tsukita, Differential
expression patterns of claudins, tight junction membrane proteins, in mouse
nephron segments, J. Am. Soc. Nephrol. 13 (2002) 875–886.
[46] C. de Roufﬁgnac, G. Quamme, Renal magnesium handling and its hormonal
control, Physiol. Rev. 74 (1994) 305–322.
[47] R. Greger, Ion transport mechanisms in thick ascending limb of Henle's loop of
mammalian nephron, Physiol. Rev. 65 (1985) 760–797.
[48] D.B. Simon, Y. Lu, K.A. Choate, H. Velazquez, E. Al-Sabban, M. Praga, G. Casari, A.
Bettinelli, G. Colussi, J. Rodriguez-Soriano, D. McCredie, D. Milford, S. Sanjad, R.P.
Lifton, Paracellin-1, a renal tight junction protein required for paracellular Mg2+
resorption, Science 285 (1999) 103–106.
[49] S. Weber, K. Hoffmann, N. Jeck, K. Saar, M. Boeswald, E. Kuwertz-Broeking, I.I. Meij,
N.V. Knoers, P. Cochat, T. Suláková, K.E. Bonzel, M. Soergel, F. Manz, K. Schaerer, H.
W. Seyberth, A. Reis, M. Konrad, Familial hypomagnesaemia with hypercalciuria
and nephrocalcinosis maps to chromosome 3q27 and is associatedwithmutations
in the PCLN-1 gene, Eur. J. Hum. Genet. 8 (2000) 414–422.
[50] S. Weber, L. Schneider, M. Peters, J. Misselwitz, G. Rönnefarth, M. Böswald, K.E.
Bonzel, T. Seeman, T. Suláková, E. Kuwertz-Bröking, A. Gregoric, J.B. Palcoux, V.
Tasic, F. Manz, K. Schärer, H.W. Seyberth, M. Konrad, Novel paracellin-1 mutations
in 25 families with familial hypomagnesemia with hypercalciuria and nephro-
calcinosis, J. Am. Soc. Nephrol. 12 (2001) 1872–1881.
[51] J. Hou, Q. Shan, T. Wang, A.S. Gomes, Q. Yan, D.L. Paul, M. Bleich, D.A. Goodenough,
Transgenic RNAi depletion of claudin-16 and the renal handling of magnesium,
J. Biol. Chem. 282 (2007) 17114–17122.
[52] P. Claude, D.A. Goodenough, Fracture faces of zonulae occludentes from “tight”
and “leaky” epithelia, J. Cell Biol. 58 (1973) 390–400.
[53] T. Hirano, N. Kobayashi, T. Itoh, A. Takasuga, T. Nakamaru, S. Hirotsune, Y.
Sugimoto, Null mutation of PCLN-1/Claudin-16 results in bovine chronic inter-
stitial nephritis, Genome Res. 10 (2000) 659–663.
[54] Y. Ohba, H. Kitagawa, K. Kitoh, Y. Sasaki, M. Takami, Y. Shinkai, T. Kunieda, A
deletion of the paracellin-1 gene is responsible for renal tubular dysplasia in
cattle, Genomics 68 (2000) 229–236.
[55] C. Sandri, J.M. Van Buren, K. Akert, Membrane morphology of the vertebrate
nervous system. A study with freeze-etch technique, Prog. Brain Res. 46 (1977)
1–384.
[56] W. Tetzlaff, The development of a zonula occludens in peripheral myelin of the
chick embryo, a freeze-fracture study, Cell Tissue Res. 189 (1978) 187–201.
[57] T. Miyamoto, K. Morita, D. Takemoto, K. Takeuchi, Y. Kitano, T. Miyakawa, K.
Nakayama, Y. Okamura, H. Sasaki, Y. Miyachi, M. Furuse, S. Tsukita, Tight junctions
in Schwann cells of peripheral myelinated axons: a lesson from claudin-19-
deﬁcient mice, J. Cell Biol. 169 (2005) 527–538.
[58] S. Angelow, R. El-Husseini, S.A. Kanzawa, A.S. Yu, Renal localization and function of
the tight junction protein, claudin-19, Am. J. Physiol. Renal Physiol. 293 (2007)
F166–F177.
[59] M. Konrad, A. Schaller, D. Seelow, A.V. Pandey, S. Waldegger, A. Lesslauer, H.
Vitzthum, Y. Suzuki, J.M. Luk, C. Becker, K.P. Schlingmann, M. Schmid, J.
Rodriguez-Soriano, G. Ariceta, F. Cano, R. Enriquez, H. Juppner, S.A. Bakkaloglu,
M.A. Hediger, S. Gallati, S.C. Neuhauss, P. Nurnberg, S. Weber, Mutations in the
tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium
wasting, renal failure, and severe ocular involvement, Am. J. Hum. Genet. 79
(2006) 949–957.
[60] T. Nitta, M. Hata, S. Gotoh, Y. Seo, H. Sasaki, N. Hashimoto, M. Furuse, S. Tsukita,
Size-selective loosening of the blood-brain barrier in claudin-5-deﬁcient mice, J.
Cell Biol. 161 (2003) 653–660.
[61] M. Furuse, T. Hirase, M. Itoh, A. Nagafuchi, S. Yonemura, S. Tsukita, S. Tsukita,
Occludin: a novel integral membrane protein localizing at tight junctions, J. Cell
Biol. 123 (1993) 1777–1788.
[62] K. Fujimoto, Freeze-fracture replica electron microscopy combined with SDS
digestion for cytochemical labeling of integral membrane proteins, application to
the immunogold labeling of intercellular junctional complexes, J. Cell Sci. 108
(1995) 3443–3449.[63] M. Saitou, M. Furuse, H. Sasaki, J.D. Schulzke, M. Fromm, H. Takano, T. Noda, S.
Tsukita, Complex phenotype of mice lacking occludin, a component of tight
junction strands, Mol. Biol. Cell 11 (2000) 4131–4142.
[64] J.D. Schulzke, A.H. Gitter, J. Mankertz, S. Spiegel, U. Seidler, S. Amasheh, M. Saitou,
S. Tsukita, M. Fromm, Epithelial transport and barrier function in occludin-
deﬁcient mice, Biochim. Biophys. Acta 1669 (2005) 34–42.
[65] L.A. Staehelin, Further observations on the ﬁne structure of freeze-cleaved tight
junctions, J. Cell Sci. 13 (1973) 763–786.
[66] J. Ikenouchi, M. Furuse, K. Furuse, H. Sasaki, S. Tsukita, S. Tsukita, Tricellulin
constitutes a novel barrier at tricellular contacts of epithelial cells, J. Cell Biol. 171
(2005) 939–945.
[67] S. Riazuddin, Z.M. Ahmed, A.S. Fanning, A. Lagziel, S. Kitajiri, K. Ramzan, S.N. Khan,
P. Chattaraj, P.L. Friedman, J.M. Anderson, I.A. Belyantseva, A. Forge, S. Riazuddin,
T.B. Friedman, Tricellulin is a tight-junction protein necessary for hearing, Am. J.
Hum. Genet. 79 (2006) 1040–1051.
[68] M.S. Chishti, A. Bhatti, S. Tamim, K. Lee, M.L. McDonald, S.M. Leal, W. Ahmad, Splice-
site mutations in the TRIC gene underlie autosomal recessive nonsyndromic
hearing impairment in Pakistani families, J. Hum. Genet. 53 (2008) 101–105.
[69] S. Tsukita, M. Furuse, M. Itoh, Multifunctional strands in tight junctions, Nat. Rev.
Mol. Cell Biol. 2 (2001) 285–293.
[70] M. Itoh, M. Furuse, K. Morita, K. Kubota, M. Saitou, S. Tsukita, Direct binding of
three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH
termini of claudins, J. Cell Biol. Dec. 147 (1999) 1351–1363.
[71] K. Umeda, J. Ikenouchi, S. Katahira-Tayama, K. Furuse, H. Sasaki, M. Nakayama, T.
Matsui, S. Tsukita, M. Furuse, S. Tsukita, ZO-1 and ZO-2 independently determine
where claudins are polymerized in tight-junction strand formation, Cell 126
(2006) 741–754.
[72] M. Adachi, A. Inoko, M. Hata, K. Furuse, K. Umeda, M. Itoh, S. Tsukita, Normal
establishment of epithelial tight junctions in mice and cultured cells lacking
expression of ZO-3, a tight-junction MAGUK protein, Mol. Cell Biol. 26 (2006)
9003–9015.
[73] J. Ikenouchi, K. Umeda, S. Tsukita, M. Furuse, S. Tsukita, Requirement of ZO-1 for
the formation of belt-like adherens junctions during epithelial cell polarization, J.
Cell Biol. 176 (2007) 779–786.
[74] Y. Ando-Akatsuka, S. Yonemura,M. Itoh, M. Furuse, S. Tsukita, Differential behavior
of E-cadherin and occludin in their colocalization with ZO-1 during the
establishment of epithelial cell polarity, J. Cell Physiol. 179 (1999) 115–125.
[75] M. Itoh, S. Yonemura, A. Nagafuchi, S. Tsukita, S. Tsukita, A 220-kD undercoat-
constitutive protein: its speciﬁc localization at cadherin-based cell–cell adhesion
sites, J. Cell Biol. 115 (1991) 1449–1462.
[76] M. Itoh, K. Morita, S. Tsukita, Characterization of ZO-2 as a MAGUK family member
associated with tight as well as adherens junctions with a binding afﬁnity to
occludin and alpha catenin, J. Biol. Chem. 274 (1999) 5981–5986.
[77] T. Katsuno, K. Umeda, T. Matsui, M. Hata, A. Tamura, M. Itoh, K. Takeuchi, T.
Fujimori, Y.I. Nabeshima, T. Noda, S. Tsukita, S. Tsukita, Deﬁciency of ZO-1 causes
embryonic lethal phenotype associated with defected yolk sac angiogenesis and
apoptosis of embryonic cells, Mol. Biol. Cell. in press
[78] V.E. Carlton, B.Z. Harris, E.G. Puffenberger, A.K. Batta, A.S. Knisely, D.L. Robinson,
K.A. Strauss, B.L. Shneider, W.A. Lim, G. Salen, D.H. Morton, L.N. Bull, Complex
inheritance of familial hypercholanemia with associated mutations in TJP2 and
BAAT, Nat. Genet. 34 (2003) 91–96.
[79] M.D. Griswold, Protein secretions of Sertoli cells, Int. Rev. Cytol. 110 (1988)
133–156.
[80] W. Vlok, J.H. Van Vuren, Chemical composition of blood and seminal plasma of
Barbus aeneus (Cyprinidae), Comp. Biochem. Physiol. A. 90 (1988) 49–51.
[81] D. Müller, P.J. Kausalya, F. Claverie-Martin, I.C. Meij, P. Eggert, V. Garcia-Nieto, W.
Hunziker, A novel claudin 16 mutation associated with childhood hypercalciuria
abolishes binding to ZO-1 and results in lysosomal mistargeting, Am. J. Hum.
Genet. 73 (2003) 1293–1301.
[82] D. Müller, P.J. Kausalya, I.C. Meij, W. Hunziker, Familial hypomagnesemia with
hypercalciuria and nephrocalcinosis: blocking endocytosis restores surface
expression of a novel Claudin-16 mutant that lacks the entire C-terminal cytosolic
tail, Hum. Mol. Genet. 15 (2006) 1049–1058.
[83] A.L. Hardison, L. Lichten, S. Banerjee-Basu, T.S. Becker, S.M. Burgess, The zebraﬁsh
gene claudinj is essential for normal ear function and important for the formation
of the otoliths, Mech. Dev. 122 (2005) 949–958.
[84] M. Bagnat, I.D. Cheung, K.E. Mostov, D.Y. Stainier, Genetic control of single lumen
formation in the zebraﬁsh gut, Nat. Cell Biol. (2007) 954–996.
[85] J. Xu, P.J. Kausalya, D.C. Phua, S.M. Ali, Z. Hossain, W. Hunziker, Early embryonic
lethality of mice lacking ZO-2, but Not ZO-3, reveals critical and nonredundant
roles for individual zonula occludens proteins in mammalian development, Mol.
Cell Biol. 28 (2008) 1669–1678.
[86] T.K. Kiener, I. Selptsova-Friedrich, W. Hunziker, Tjp3/zo-3 is critical for epidermal
barrier function in zebraﬁsh embryos, Dev. Biol. 316 (2008) 36–49.
[87] L. Guillemot, S. Paschoud, P. Pulimeno, A. Foglia, S. Citi, The cytoplasmic plaque of
tight junctions: a scaffolding and signalling center, Biochim. Biophys. Acta 1778
(2008) 601–613.
[88] K. Matter, M.S. Balda, Epithelial tight junctions, gene expression and nucleo-
junctional interplay, J. Cell Sci. 120 (2007) 1505–1511.
